The Impact of Infusion Reactions on Oncology Patients and Clinicians in the Inpatient and Outpatient Practice Settings
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 30 (3) , 153-160
- https://doi.org/10.1097/01.nan.0000270674.13439.5b
Abstract
Cancer patients treated with parenteral chimeric or humanized monoclonal antibody agents or chemotherapy are at risk of experiencing an infusion reaction. The impact of infusion reactions can be substantial. Infusion reactions, even when mild, can be disruptive and stressful. In-person interviews with 202 nurses were conducted at the 2005 Annual Oncology Nursing Society Congress to evaluate the impact of infusion reactions on patients and nurses in the inpatient and outpatient practice settings. Results from this survey study suggest that infusion reactions have a significant negative impact on both patients and nurses.Keywords
This publication has 5 references indexed in Scilit:
- Management of the Patient Receiving Parenteral Biologic TherapyJournal of Infusion Nursing, 2006
- Monoclonal antibodies in the treatment of cancer, Part 2.American Journal of Health-System Pharmacy, 2003
- Monoclonal antibodies in the treatment of cancer, Part 1.American Journal of Health-System Pharmacy, 2003
- Anticancer AntibodiesAmerican Journal of Clinical Pathology, 2003
- Infusion Reactions Associated with the Therapeutic Use of Monoclonal Antibodies in the Treatment of MalignancyCancer and Metastasis Reviews, 1999